This is your reminder to register for the FREE and LIVE webinar “Rescheduling or Descheduling: How Future Federal Decisions May Impact the Industry” produced by Cannabis Business Times and Cannabis Conference on Nov. 7 at 1 p.m. ET.

We’ll be covering the practical consequences of President Biden’s instruction to the secretary of Health and Human Services and attorney general to review cannabis’ Schedule I status in the Controlled Substances Act.

The big question here is: What does that mean for us?

Learn how your cannabis business can prepare for the future as we discuss the following:

• The actual process that the Biden administration is undertaking
• The ways in which rescheduling or descheduling cannabis would impact the industry
• The ways in which businesses can secure GMP compliance ahead of possible FDA oversight
• The ways in which access to capital may change under federal intervention
• The possible effects on interstate commerce and international trade